TrialPsychopharmacology2018

The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial.

Douglas L Boggs et al.PubMed ↗Publisher ↗

No numbers read from the abstract.